Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Respicardia Stock

Q: How to sell Respicardia stock?

If you hold private company shares of Respicardia - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Respicardia stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

respicardia.comHealthcare / Other HealthcareFounded: 2006Funding to Date: $153.45MM

Respicardia is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health.

Buy or sell Respicardia stockLearn more about Respicardia IPO

OverviewFinancingsValuation

Enterprise Value

Access Respicardia’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Respicardia.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Timothy Hauch

Chief Financial Officer

Todd Goblish

Vice President, Research & Development

Peter Sommerness

Chief Executive Officer

Linda Nelson

Vice President, Clinical Affairs

Bonnie Labosky

Chief Executive Officer, Board Member & President

Frank Piskolich JD

General and IP Counsel

Robin Germany MD

Chief Medical Officer

Board Members

Kristine Johnson

Affinity Capital Management

Thomas Weldon

Accuitive Medical Ventures

William Abraham MD

Kirk Nielsen

Versant Venture Management

Wilfred Jaeger MD

Three Arch Partners

Zack Scott MD

Revelation Partners

Kevin Wasserstein

Versant Venture Management

Scott Ward

Edward Andrle

Sorin

Respicardia stock FAQs

Can you buy Respicardia stock?

As Respicardia is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Respicardia, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Respicardia stock?

To invest in a private company like Respicardia through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Respicardia stock?

Yes, you may be able to sell your Respicardia stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Respicardia stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Respicardia stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Respicardia a public company?

No, Respicardia is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Respicardia’s stock price?

Respicardia is a privately held company and therefore does not have a public stock price. However, you may access Respicardia’s private market stock price with Forge Data.

What is Respicardia’s stock ticker symbol?

Respicardia does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Wall Street Journal 10/29/2014

Sorin Group Takes $20M Stake in Respicardia, With Option to Acquire

Respicardia Inc. has received a $20 million investment from Sorin Group and sold select European distribution rights for its implantable sleep apnea device to the Italian medical-device company.

Mass Device 10/22/2014

Sorin drops $20m on stake in Respicardia

Sorin Group (BIT:SRN) said it invested $20 million in a minority stake and controlling option in Minnetonka, Minn.-based Respicardia, which is developing implantable devices to treat central sleep apnea.

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.